808 related articles for article (PubMed ID: 31426125)
1. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
5. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
[TBL] [Abstract][Full Text] [Related]
6. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
8. Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study.
Kawamura K; Ichikado K; Anan K; Yasuda Y; Sekido Y; Suga M; Ichiyasu H; Sakagami T
Chron Respir Dis; 2020; 17():1479973120909840. PubMed ID: 32141310
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
[TBL] [Abstract][Full Text] [Related]
12. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
Walsh SLF; Wells AU; Desai SR; Poletti V; Piciucchi S; Dubini A; Nunes H; Valeyre D; Brillet PY; Kambouchner M; Morais A; Pereira JM; Moura CS; Grutters JC; van den Heuvel DA; van Es HW; van Oosterhout MF; Seldenrijk CA; Bendstrup E; Rasmussen F; Madsen LB; Gooptu B; Pomplun S; Taniguchi H; Fukuoka J; Johkoh T; Nicholson AG; Sayer C; Edmunds L; Jacob J; Kokosi MA; Myers JL; Flaherty KR; Hansell DM
Lancet Respir Med; 2016 Jul; 4(7):557-565. PubMed ID: 27180021
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognosis of unclassifiable interstitial lung disease.
Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of interstitial lung diseases in central Denmark.
Hyldgaard C; Hilberg O; Muller A; Bendstrup E
Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
[TBL] [Abstract][Full Text] [Related]
15. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
[TBL] [Abstract][Full Text] [Related]
16. ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.
Hirata M; Hara Y; Fujii H; Murohashi K; Saigusa Y; Zhao S; Kobayashi M; Nagasawa R; Tagami Y; Izawa A; Otsu Y; Watanabe K; Horita N; Kobayashi N; Kaneko T
BMC Pulm Med; 2024 Jan; 24(1):16. PubMed ID: 38183005
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.
Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y
Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077
[TBL] [Abstract][Full Text] [Related]
18. Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.
Okuda R; Takemura T; Misumi T; Nagasawa R; Iwasawa T; Baba T; Hagiwara E; Ogura T
Respiration; 2023; 102(9):803-812. PubMed ID: 37619546
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
